Sen. Markwayne Mullin sold Abbott Laboratories (ABT)
Sen. Markwayne Mullin (R-OK) · $1K–$15K · traded Jan 8, 2025
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jan 8, 2025
- Disclosed
- Jan 31, 2025
- Days to disclose
- 23
- Asset type
- Stock
- As filed
- Abbott Laboratories
- Industry
- Medical - Devices · Healthcare
Other trades in this filing
All of Mullin's trades →- Jan 31, 2025$1K–$15K
Sold (full) KAUKAUNA WIS ANTIC NTS 2023B Rate/Coupon: 5.0% Matures: 06/01/28
$1K–$15K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$50K–$100K
$50K–$100K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
Sold (partial) SALEM N H GO BDS Rate/Coupon: 4.0% Matures: 10/01/36
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
Sold (partial) iShares Core MSCI EAFE ETF IEFA
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
Sold (partial) VANGUARD INDEX FDS VANGUARD MID-CAP ETF
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$50K–$100K
$50K–$100K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$50K–$100K
Sold (partial) AUSTIN TEX CTFS OBLIG 2023 Rate/Coupon: 5.0% Matures: 09/01/38
$50K–$100K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
Sold (partial) iShares MSCI Eurozone ETF EZU
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$50K–$100K
Sold (partial) NEVADA ST LTD TAX GO CAP IMPT BDS Rate/Coupon: 5.0% Matures: 05/01/38
$50K–$100K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 8, 2025 · disclosed Jan 31, 2025 · Joint
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025 · Spouse
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025 · Spouse
- Jan 31, 2025$15K–$50K
Bought Westinghouse Air Brake Technologies WAB
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025
- Jan 31, 2025$15K–$50K
Bought Applied Industrial Technologies AIT
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025 · Spouse
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025
- Jan 31, 2025$15K–$50K
Bought Credo Technology Group Holding CRDO
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025
- Jan 31, 2025$15K–$50K
$15K–$50K · Traded Jan 2, 2025 · disclosed Jan 31, 2025 · Spouse
Recent Congress trades in ABT
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 28, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 28, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Aug 19, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 19, 2026 · Spouse
Committee overlap: Energy and Commerce - Aug 17, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 17, 2026
- Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
Sold (full) Abbott Laboratories ABT
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.